Cargando…

Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System

Detalles Bibliográficos
Autor principal:	Dorszewska, Jolanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958953/ https://www.ncbi.nlm.nih.gov/pubmed/24653657 http://dx.doi.org/10.2174/138920291501140306110937

Ejemplares similares

Genetic Variants in Diseases of the Extrapyramidal System
por: Oczkowska, Anna, et al.
Publicado: (2014)

Genetic Factors in Parkinson’s Disease
por: Dorszewska, Jolanta
Publicado: (2013)

Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Oxidative stress factors in Parkinson’s disease
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism
por: Roiter, Beatrice, et al.
Publicado: (2020)

Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2015)

Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus
por: Li, Wanyao, et al.
Publicado: (2022)

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2013)

The Diethylaminoethylester of Phenylcyclopentane Carboxylic Acid (Parpanit) Geigy in the Treatment of Diseases of the Extrapyramidal Motor System
Publicado: (1949)

Drug-Induced Extrapyramidal Syndromes
por: Lader, M. H.
Publicado: (1970)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment
por: Rozycka, Agata, et al.
Publicado: (2013)

Special Issue “Parkinson’s Disease: Genetics and Pathogenesis”
por: Lesage, Suzanne, et al.
Publicado: (2023)

Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang, Yang-Pei, et al.
Publicado: (2019)

Parkinson’s disease as a systemic pathology
por: Ezquerra, Mario, et al.
Publicado: (2019)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

FLUOXETINE INDUCED EXTRAPYRAMIDAL SYMPTOMS : CASE REPORTS
por: Nizamie, S. Haque, et al.
Publicado: (1998)

Dothiepin-induced transient hypomania and extrapyramidal syndrome
por: Inamdar, Amir, et al.
Publicado: (2013)

MICU1- Related Myopathy with Extrapyramidal Signs
por: Mukherjee, Debaleena, et al.
Publicado: (2023)

Chronic subdural haematoma mimicking extrapyramidal symptoms
por: Cheng, Po Wen, et al.
Publicado: (2023)

Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases
por: Tarín, Juan J, et al.
Publicado: (2015)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Novel SERAC1 Variant Presenting With Adult-Onset Extrapyramidal Dystonia-Parkinsonism Phenotype: A Case Report
por: Ashton, Catherine, et al.
Publicado: (2023)

Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
por: Avgerinos, Konstantinos I., et al.
Publicado: (2023)

Extrapyramidal signs in normal pressure hydrocephalus: an objective assessment
por: Mandir, Allen S, et al.
Publicado: (2007)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang, Lian-fang, et al.
Publicado: (2016)

Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose
por: Das, Soumitra, et al.
Publicado: (2018)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Genotype, extrapyramidal features, and severity of variant ataxia‐telangiectasia
por: Schon, Katherine, et al.
Publicado: (2019)

Post-Mumps Extrapyramidal Syndrome in a Young Child
por: Verma, Rajesh, et al.
Publicado: (2021)

Acute Extrapyramidal Side Effects from Smoked Haloperidol
por: Pham, Angeline, et al.
Publicado: (2021)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Extrapyramidal syndrome in psychotic depression: a case report.
por: Álvarez, C., et al.
Publicado: (2023)

Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy
por: Musco, Shaina, et al.
Publicado: (2019)

Rare presentation of a common disease: Idiopathic hypoparathyroidism presenting with extrapyramidal symptoms and status epilepticus
por: Ghosh, Kaushik, et al.
Publicado: (2012)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n4cd4ki29c5u75mijivj9nhjnf